VIBRIOVEC Trademark

Trademark Overview


On Tuesday, September 17, 2002, a trademark application was filed for VIBRIOVEC with the United States Patent and Trademark Office. The USPTO has given the VIBRIOVEC trademark a serial number of 78164821. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 30, 2024. This trademark is owned by Avant Immunotherapeutics, Inc.. The VIBRIOVEC trademark is filed in the Pharmaceutical Products category with the following description:

Attenuated Vibrio cholera strains for administration to humans for delivery of heterologous antigens, for providing protective immunity for the prevention and treatment of infectious diseases
vibriovec

General Information


Serial Number78164821
Word MarkVIBRIOVEC
Filing DateTuesday, September 17, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 30, 2024
Registration Number2815820
Registration DateTuesday, February 17, 2004
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 6, 2003

Trademark Statements


Goods and ServicesAttenuated Vibrio cholera strains for administration to humans for delivery of heterologous antigens, for providing protective immunity for the prevention and treatment of infectious diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 30, 2024
Primary Code005
First Use Anywhere DateFriday, August 21, 1998
First Use In Commerce DateMonday, September 22, 2003

Trademark Owner History


Party NameCELLDEX THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressNEEDHAM, MA 02494

Party NameAvant Immunotherapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNeedham, MA 02194

Party NameAvant Immunotherapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNeedham, MA 02194

Party NameAvant Immunotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNeedham, MA 02194

Trademark Events


Event DateEvent Description
Tuesday, May 6, 2003PUBLISHED FOR OPPOSITION
Friday, February 21, 2003ASSIGNED TO EXAMINER
Friday, February 21, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 16, 2003NOTICE OF PUBLICATION
Thursday, November 6, 2003PAPER RECEIVED
Tuesday, December 23, 2003ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 17, 2004REGISTERED-PRINCIPAL REGISTER
Monday, August 16, 2010TEAS SECTION 8 & 15 RECEIVED
Thursday, September 2, 2010CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, September 2, 2010REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 29, 2003NOA MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 6, 2003USE AMENDMENT FILED
Thursday, November 6, 2003STATEMENT OF USE PROCESSING COMPLETE
Monday, December 22, 2003CASE FILE IN TICRS
Tuesday, December 23, 2003ASSIGNED TO EXAMINER
Wednesday, April 1, 2009AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, March 3, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Monday, March 25, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 25, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 13, 2014TEAS SECTION 8 & 9 RECEIVED
Thursday, February 13, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Monday, March 3, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, March 3, 2014REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, March 3, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, February 17, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Friday, August 30, 2024CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9